Tenax Therapeutics, Inc. (TENX)
2.13
-0.06
(-2.74%)
USD |
NASDAQ |
Aug 28, 16:00
2.135
0.00 (0.00%)
After-Hours: 20:00
Tenax Therapeutics Free Cash Flow : -46.03M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -46.03M |
| March 31, 2026 | -38.14M |
| December 31, 2025 | -35.80M |
| September 30, 2025 | -25.91M |
| June 30, 2025 | -19.84M |
| March 31, 2025 | -16.61M |
| December 31, 2024 | -14.81M |
| September 30, 2024 | -12.46M |
| June 30, 2024 | -11.45M |
| March 31, 2024 | -9.344M |
| December 31, 2023 | -5.904M |
| September 30, 2023 | -7.038M |
| June 30, 2023 | -8.288M |
| March 31, 2023 | -10.80M |
| December 31, 2022 | -12.02M |
| September 30, 2022 | -12.48M |
| June 30, 2022 | -12.17M |
| March 31, 2022 | -10.58M |
| December 31, 2021 | -10.86M |
| September 30, 2021 | -10.08M |
| June 30, 2021 | -9.444M |
| March 31, 2021 | -9.826M |
| December 31, 2020 | -9.276M |
| September 30, 2020 | -9.012M |
| June 30, 2020 | -8.409M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.094M |
| December 31, 2019 | -7.560M |
| September 30, 2019 | -7.033M |
| June 30, 2019 | -6.806M |
| March 31, 2019 | -6.082M |
| December 31, 2018 | -5.507M |
| September 30, 2018 | -5.590M |
| June 30, 2018 | -5.261M |
| March 31, 2018 | -9.666M |
| December 31, 2017 | -12.14M |
| September 30, 2017 | -13.97M |
| June 30, 2017 | -17.02M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| July 31, 2015 | -11.72M |
| April 30, 2015 | -9.854M |
| January 31, 2015 | -11.23M |
| October 31, 2014 | -10.72M |
| July 31, 2014 | -9.810M |
| April 30, 2014 | -9.409M |
| January 31, 2014 | -7.881M |
| October 31, 2013 | -5.906M |
| July 31, 2013 | -5.023M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | -6.385M |
| Century Therapeutics, Inc. | -88.07M |
| Absci Corp. | -108.97M |
| Celularity, Inc. | -13.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.15M |
| Cash from Financing (Quarterly) | 13.37M |
| Free Cash Flow Per Share (Quarterly) | -0.2782 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.15M |
| Free Cash Flow Yield | -48.90% |